CHIKUNGUNYA

Chikungunya is a mosquito-borne viral disease that has been identified in >110 countries

OVERVIEWSIGNS & SYMPTOMSDISEASE PROTECTION

On this page:

WAYS TO REDUCE THE RISK OF CONTRACTING CHIKUNGUNYA

Vaccination is the most effective way to protect against chikungunya.1,2

In addition to vaccination, travellers can help reduce their risk of CHIKV infection by taking personal protective measures against mosquito bites.3

ENVIRONMENTAL PROTECTION

Secure sleeping areas with mosquito nets and use air conditioning indoors4,5

EXPOSURE

Reduce exposure to mosquitoes during peak biting hours (dawn and dusk for Aedes mosquitoes)4,5

BARRIER PROTECTION

Wear loose, long sleeved clothing and use an insect repellent containing Picaridin 20%, 50% DEET, eucalyptus oil, or IR35354

VACCINATION CAN PROTECT AGAINST CHIKUNGUNYA

While there is currently no specific treatment for chikungunya, vaccines give effective protection.1,2 An individual risk assessment can identify travellers who are eligible for chikungunya vaccination.6

In general chikungunya vaccination may be recommended for:

TRAVELLERS DURING OUTBREAKS3
LONGER-TERM TRAVELLERS OR PEOPLE MOVING TO AN AT-RISK COUNTRY3
TRAVELLERS VISITING FRIENDS AND FAMILY3
ADVENTURE TOURISTS3

You can help protect travellers from the risk of chikungunya with IXCHIQ®▼ chikungunya vaccine (live).7

LEARN MORE ABOUT CHIKUNGUNYA

Get in-depth info on signs, symptoms, disease protection and more.

CHIKUNGUNYA

OVERVIEW

Gain a useful overview of this potentially fatal but vaccine-preventable disease.

CHIKUNGUNYA

SIGNS & SYMPTOMS

Spot the signs that may indicate chikungunya and learn more about the disease’s lasting effects.

Useful Links
References
  1. Kang H. Vaccinating children key to protection against chikungunya. London School of Hygiene and Tropical Medicine. December 2025. Available at: https://www.lshtm.ac.uk/newsevents/news/2026/vaccinating-children-key-protection-against-chikungunya. Accessed: August 2026.
  2. Kling K, Falman A, Branke L, et al. Vaccination against chikungunya - a systematic review on the immunogenicity, tolerability, and safety of the live-attenuated vaccine (LAV) Ixchiq and the virus like particle (VLP) vaccine Vimkunya. Vaccine. 2026;75:128251.
  3. Centers for Disease Control and Prevention. Chikungunya. Yellow Book. January 2026. Available at: https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/chikungunya.html. Accessed: August 2026.
  4. NaTHNaC Travel Health Pro. Insect and tick bite avoidance. March 2024. Available at: https://travelhealthpro.org.uk/factsheet/38/insect-and-tick-bite-avoidance. Accessed: August 2026.
  5. NaTHNaC Travel Health Pro. Japanese encephalitis. June 2026. Available at: https://travelhealthpro.org.uk/factsheet/55/japanese-encephalitis. Accessed: August 2026.
  6. GOV.UK. Chikungunya vaccine in UK travellers: JCVI advice. March 2026. Available at: https://www.gov.uk/government/publications/chikungunya-vaccine-for-uk-travellers-jcvi-advice-16-july-2025/chikungunya-vaccine-in-uk-travellers-jcvi-advice. Accessed: August 2026.
  7. IXCHIQ. Summary of Product Characteristics. March 2026. Available at: https://www.medicines.org.uk/emc/product/100652/smpc. Accessed: August 2026.

UK-CH-2600004 (v2.0) August 2026